Astec Lifesciences Rights Issue 2025 Details, Record Date, Issue Price

Astec Lifesciences Rights Issue details are now available. The firm plans to issue 28,01,673 equity shares amounting to Rs 249.35 crores. Astec Lifesciences Rights issue price is Rs 890 per share, and the face value is Rs 10 per share.

Astec Lifesciences Rights Issue open date is July 14, 2025, and the close date is July 28, 2025. Astec Lifesciences rights issue entitlement ratio is 1:7, which is 1 Rights Equity Shares for every 7 fully paid-up Equity Shares held on the record date.

Astec Lifesciences Rights Issue record date is July 4, 2025. The last date to buy shares of Astec Lifesciences is July 3, 2025. This rights Issue subscription status will be available soon.

Astec Lifesciences Rights Issue Allotment date, Credit date and the Listing date will be available soon. However, the listing will be on the BSE and NSE platforms.

Astec Lifesciences rights issue registrar and the book-running lead manager(s) has not yet been disclosed.

Also Read | Infibeam Avenues Rights Issue 2025 Details, Record Date, Issue Price

Astec Lifesciences Rights Issue Details

Astec Lifesciences Rights Issue details are as follows: the company plans to issue 28,01,673 equity shares, aggregating the amount of Rs 249.35 crores. Astec Lifesciences Rights issue price is Rs 890 per share. The rights issue entitlement ratio is 1:7, which is 1 Rights Equity Share(s) for every 7 fully paid-up equity share(s).

Astec Lifesciences Rights Issue Dates

Astec Lifesciences Rights issue record date is July 4, 2025, and the last date to buy shares of Astec Lifesciences is July 3, 2025.

Astec Lifesciences Rights Issue Subscription

Astec Lifesciences Rights Issue subscription status will be available soon. The details of Rights Issue entitlement are 1 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s) held on Record Date. Astec Lifesciences issue price is Rs 890 per share.

Astec Lifesciences Limited: About the Company

Astec Lifesciences Limited, established in 1994, is a leading Indian manufacturer specializing in agrochemical active ingredients, bulk formulations, and pharmaceutical intermediates. Headquartered in Mumbai, the company operates primarily in the B2B segment, supplying products both domestically and to over 24 countries worldwide. Astec’s portfolio includes triazole fungicides, herbicides, insecticides, and specialty chemicals, widely used for crop protection and seed treatment in major crops such as cotton, maize, barley, rice, and wheat. The company is also engaged in custom synthesis projects for global clients, particularly in Europe, Japan, and the US. Since its acquisition by Godrej Agrovet Limited in 2015, Astec Lifesciences has expanded its focus on innovation and contract manufacturing, supporting sustainable agriculture through advanced chemical solutions. Its commitment to quality and global reach positions Astec as a trusted partner in the agrochemical and pharmaceutical sectors.

Astec Lifesciences Limited Financials (Amount in Rs crore)

Astec Lifesciences Rights Issue Registrar

Astec Lifesciences rights issue registrar and the book-running lead manager(s) for this rights issue have not yet been disclosed. 

FAQs

1. What are the details of the Astec Lifesciences Rights Issue?

Astec Lifesciences Rights Issue details are as follows: Astec Lifesciences plans to issue 28,01,673 equity shares amounting to Rs 249.35 crores. Astec Lifesciences Rights issue price is Rs 890 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 1:7, which is 1 Rights Equity Share(s) for every 7 fully paid-up equity share(s).

2. Astec Lifesciences Rights Issue open date and close date?

Astec Lifesciences Rights Issue's open date is July 14, 2025, and the closing date is July 28, 2025. Astec Lifesciences Rights Issue record date is July 4, 2025. The last date to buy shares of Astec Lifesciences is July 3, 2025.

3. How can I apply for the Astec Lifesciences Rights Issue?

You can apply for Astec Lifesciences in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Astec Lifesciences Rights Issue?

Astec Lifesciences rights issue entitlement ratio is 1:7, which is 1 Rights Equity Share(s) for every 7 fully paid-up equity share(s).

5. How can I check the Astec Lifesciences Issue Allotment Status?

The registrar for this upcoming rights issue is not yet disclosed. Once it is available investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Letter of Offer Astec Lifesciences Rights issue?

You can download the Astec Lifesciences Rights issue Letter of Offer by visiting here.

7. What is the listing date of the Astec Lifesciences Rights Issue?

The Astec Lifesciences Rights Issue listing date will be available soon. However, the listing will be on the BSE and NSE exchanges.

8. Who are the registrar and lead managers of the Astec Lifesciences Rights Issue?

Astec Lifesciences Limited's rights issue registrar and the book-running lead manager(s) for this rights issue have not yet been disclosed.

Also Read | Capital Trust Rights Issue 2025 Details, Record Date, Issue Price